This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
By Larry K. Houck Last month the U.S. Attorneys Office for the Northern District of Illinois announced that Walgreens agreed to pay up to $350,000,000 to resolve allegations that its pharmacies illegally filled millions of invalid prescriptions for opioids and other controlled substances in violation of the federal Controlled Substances Act, and sought payment for filling many of those prescriptions by federal health care programs, violating the False Claims Act.
A new framework for Covid-19 vaccines announced by Food and Drug Administration leaders Tuesday suggests the agency will no longer approve new Covid vaccines for healthy individuals under 65, including babies, without data from new randomized clinical trials showing their benefit. The plan — described in a commentary in the New England Journal of Medicine, followed by a live stream on YouTube — created confusion among physicians about what it means for young children.
The agency will now require randomized, controlled data before approving new COVID shots for healthy children and adults, Commissioner Martin Makary and top vaccine official Vinay Prasad wrote in NEJM.
Community pharmacy was the most accessible healthcare location for the public last winter, ahead of general practice, dentists and hospital services, polling by YouGov has found. Almost six in 10 people who tried to access community pharmacies last winter found it easy to do so, compared to just four in 10 who could easily access […] The post Pharmacies voted most accessible healthcare location appeared first on The Pharmacist.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Duck Creek Technologies has appointed Tyler Jones as its new chief marketing officer (CMO). He will lead the companys global marketing strategy, supporting its position as a provider of property and casualty (P&C) insurance software. Jones brings more than two decades of experience at the intersection of insurance, technology and customer experience.
For decades, mainstream nutrition guidelines have recommended that Americans replace animal fats like butter or lard with polyunsaturated fats, especially seed oils such as soybean, corn, and sunflower oils. These oils are rich in omega-6 fatty acids and now make up a significant portion of the fat consumed in the standard American diet. But recently, the conversation has shifted.
The 5th Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) will gather industry leaders in Vsendorf, Austria on 24-25 November for indepth case studies, practical workshops and highimpact networking designed to accelerate pharmas digital journey.
Brand shifts away from dieting towards weight-loss injections after filing for bankruptcy in the US WeightWatchers is teaming up with a provider of weight-loss drugs such as Wegovy and Mounjaro, in a seismic shift for the brand away from a focus on dieting as it tries to turn around its struggling business. WeightWatchers, which has promoted a non-medical, points-based approach to food intake since its creation in the 1960s , has announced a strategic partnership in the UK with CheqUp, a provide
Of the seven health tech companies that met with the government’s most powerful health official on Monday, all but one had something in common: Financial backing from one of Silicon Valley’s top venture capital firms. In a post on the social media platform X, the Department of Health and Human Services announced that health secretary Robert F.
Senores Pharmaceuticals, through its wholly-owned subsidiary Senores Pharmaceuticals, USA, has signed an agreement to acquire the USFDA-approved Abbreviated New Drug Application (ANDA) for Enalapril Maleate Tablets 2.5mg, 5mg, 10mg and 20mg from Wockhardt. Enalapril is indicated as a treatment of hypertension, heart failure, and asymptomatic left ventricular dysfunction.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Dr. Adam J. Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCIs new live video webinar: Whats Next for Retail Pharmacy: Data, Debate, and Disruption This event will be broadcast live on: Friday, June 20, 2025 12:00 p.m. to 1:30 p.m. ET Dr. Fein will be joined by special guest Antonio Ciaccia, CEO of 46brooklyn Research , and President of 3 Axis Advisors.
In a notable development, Maryland Gov. Wes Moore signed a bill that will allow a state board to extend its mandate for lowering prescription drug costs to all residents, not just those employed by government agencies. The move was hailed by consumer advocates who hope the Prescription Drug Affordability Board, which is designed to function much like a state utility commission, will usher in era of lower medicine prices for everyone who lives in Maryland.
Barentz, a specialty ingredients solutions provider, has entered into exclusive discussions to acquire 100 per cent equity of Fengli Group, a specialty chemicals distributor for pharmaceutical excipients and active ingredients in China. Established in 1996 and headquartered in Beijing, Fengli Group comprises a team of over 100 experienced professionals across five locations in mainland China.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Pharmacies have been advised that the brand Nystan 100,000units/ml oral suspension (ready mixed) (Vygoris Ltd)30 ml has been discontinued. The branded oral suspension, used for oral thrush, is no longer available for pharmacies to order and instead a generic Nystatin 100,000units/ml oral suspension should be ordered from wholesalers. The discontinuation raises potential price issues, as […] The post Nystan oral suspension discontinued appeared first on The Pharmacist.
Developers of digital mental health treatments now have fresh economic data to help make the case for broader coverage of their apps. Companies selling Food and Drug Administration-cleared apps for the treatment of psychiatric and other conditions have long struggled with adoption by patients, providers, and payers for many reasons. Clinical evidence supporting these prescription digital therapeutics has gradually improved , but policymakers and insurers have been hesitant to open the path to re
As clinical trial designs become more complex, the requirements for participation from both a patient and trial site perspective have also evolved. With compliance being a factor for success, sponsors are being pushed to rethink how they manage and capture clinical outcome assessments (COAs). Speed, scale and precision are no longer simply nice to have, they are the foundation of a successful study.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Selecting the right pharma marketing vendor in 2025 is no longer a simple matter of comparing capabilities or price points. The explosion of digital channels, AI-driven targeting, and compliance complexity has redefined what pharma marketers need from external partners. Whether youre launching a blockbuster brand like Tirzepatide or navigating market access challenges for a biosimilar, your vendors expertise can directly impact your outcomes.
Tourmaline Bio disclosed results for a potential rival to a Novo Nordisk drug. Elsewhere, data emerged for a psychedelic and CRISPR Therapeutics expanded its toolkit.
Sen. Lisa Blunt Rochester has written a stinging letter to Health Secretary Robert F. Kennedy Jr. demanding that he clarify whether the Centers for Disease Control and Prevention has an acting director. In her three-page missive, Blunt Rochester suggested that Matthew Buzzelli, the person Kennedy said was the CDC’s acting director, cannot hold the role because he isn’t qualified under the federal Vacancies Act.
"Patent Expiration: The Secret to Unlocking a $1 Trillion Market Opportunity As the pharmaceutical industry continues to shift towards generics, one thing is clear: the next big winners will be those who can identify and capitalize on the impending patent expirations of blockbuster drugs. According to our analysis of patent expiration data, the next 5 years will see the loss of exclusivity for over 200 top-selling medications, with a combined market value of over $1 trillion.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Imagine youre trying to reach a specialist in a bustling hospitalyour message is a whisper in a sea of noise. How do you get through? In the complex world of healthcare, pharmaceutical marketing strategies must evolve to genuinely connect with healthcare professionals (HCPs). No longer effective are blanket tactics or generic messaging. Instead, today’s successful marketers are leveraging personalized, data-driven, and omnichannel approaches that meet HCPs where they are.
New research reveals that financial institutions are deep into digital transformationbut data strategy, AI implementation, and legacy systems are proving to be the fault lines. From cloud infrastructure to GenAI, and digital assets to cybersecurity, financial firms are investing heavily to modernize their operations and stay competitive. Yet a new study shows that even as budgets rise and digital ambitions grow, most institutions are still struggling to align strategy with execution.
Top of the morning to you, and a fine one it is. Clear, blue skies and comfortable breezes are enveloping the Pharmalot campus, where the short person is sleeping in and the official mascots are threatening local cats to keep their distance. As for us, we are engaged in the usual rituals — firing up the coffee kettle in order to brew a cup of stimulation (the choice today is pecan bourbon) and foraging for items of interest.
In this episode, Ill discussthree ways to tell the difference between serotonin syndrome and neuroleptic malignant syndrome. Episode 1028: Three ways to tell the difference between serotonin syndrome and neuroleptic malignant syndrome Subscribe on iTunes , Android , or Stitcher Muscular rigidity, significant hyperthermia, and autonomic instability are all common features of serotonin syndrome and neuroleptic malignant syndrome.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Data from Avaloq reveals shifting investor expectations, growing tech dissatisfaction among wealth managers, and opportunities for platform modernizationinsights that matter to anyone investing in or advising financial firms. The Avaloq Wealth Insights 2024 report, developed in partnership with Phronesis Partners , is based on surveys with 3,000+ investors and over 300 wealth professionals across Europe, Asia, and the Middle East, reveals major disconnects between what investors expect and how
Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Good morning health tech readers!
Patient-centric, large-scale real-world studies, which use data collected outside the system of controlled clinical trials, can and have already been delivered successfully. The tools, systems, and processes are available today, and modern technology has made it much easier to successfully run a real-world CNS study.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
64 
Let's personalize your content